Overview A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) Status: Completed Trial end date: 2009-10-01 Target enrollment: Participant gender: Summary A study to evaluate the safety, tolerability, and efficacy of MK-0773 in women with sarcopenia (loss of muscle mass). Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.